Verrica Pharmaceuticals (VRCA)

• Market cap: $34.1M
• 1 day: -0.28%
• 5 days: -7.44%
• 1 month: -16.05%
• 3 months: -42.15%
• 6 months: -21.52%
• Year to date: -48.65%
• 1 year: -78.51%
• 5 years: -95.26%
• 10 years: -97.94%
• Sector: Healthcare
• Industry: Biotechnology

About: Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.

Employees: 71